Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of Belotero® Intense Lidocaine for Lip Augmentation

NCT05773066 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.

NCT NCT05773066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05773066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of Belotero® Intense Lidocaine for Lip Augmentation
Lead sponsor
Merz North America, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 3, 2023
Completion date
September 26, 2024
Enrollment
220 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

lip augmentation